直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

We share our Insights on a regular basis.

Media Contacts
Terra Liddell
Chief Marketing Officer
Washington, DC
Email
Angela Robinson
Director of Branding and Communications
Washington, DC
Email

IP Updates

Unified Patent Court (UPC) Hub

2026

Articles

When the Classroom Goes Dark: Lessons from the Canvas Breach for Corporate Cyber Preparedness

July 8, 2026

Articles

Enforcing Your Patent Rights at Sea: A UK Perspective

June 18, 2026

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

Articles

Highlights and Implications of the UK Corporate Plan for the UKIPO

July 17, 2026

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

IP Updates

Too Concrete to Fail: Ceiva’s Guidance on the Use of Sufficiently Concrete Structures to Overcome Section 101 Rejections

July 28, 2026

At the PTAB Blog

Deadline Evolution: Director Extends Deadline for Requesting Director Review of Institution Grants to 30 Days

June 30, 2026

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Never miss an Insight.

Sign up

Recent Insights

to

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

Conference

Investival Showcase USA Investival Showcase USA

March 10-11, 2026

Miami

Conference

Georgia Life Sciences Summit 2025 Georgia Life Sciences Summit 2025

August 26-27, 2025

Sandy Springs

Conference

4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA

October 8-24, 2024

Virtual

Webinar

Section 102 and Prior Art: Navigating the Expanded Scope of Prior Art and AIA Exceptions Section 102 and Prior Art: Navigating the Expanded Scope of Prior Art and AIA Exceptions

August 7, 2024

Webinar

Conference

4th Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction Workshop 4th Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction Workshop

June 10-11, 2024

Basel

Seminar

Judicial Colloquium on Intellectual Property Judicial Colloquium on Intellectual Property

April 29-May 2, 2024

Alexandria

Webinar

Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation

February 15, 2024

Webinar

Webinar

Discovery in U.S. Patent Litigation & Managing its Potential Impact in Related Foreign Cases Discovery in U.S. Patent Litigation & Managing its Potential Impact in Related Foreign Cases

January 18, 2023

Webinar

Webinar

A Fresh Look at Chemical and Pharmaceutical Selection Inventions: U.S. and European Perspectives A Fresh Look at Chemical and Pharmaceutical Selection Inventions: U.S. and European Perspectives

December 20, 2022

Webinar

Hybrid Conference

ABA’s Business Law Section Hybrid Spring Meeting 2022 ABA’s Business Law Section Hybrid Spring Meeting 2022

March 31-April 2, 2022

Atlanta

Webinar

Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation

February 16, 2022

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP